US Commerce officials upset Beijing when they added 33 Chinese entities to its list of unverified exporters, as that strangles China’s tech supply chain at its most vulnerable points, the SCMP said
The recommendation, which sent Innovent shares down, raises concerns for other Chinese drugmakers seeking to bring products to the US market
Beijing said it had worked hard to promote its Phase 1 economic and trade agreement and overcame multiple negative impacts
Studios got to access an enormous and fast-growing market, and China’s citizens got to enjoy America’s blockbusters
Sintilimab, made by Suzhou-based Innovent and US drugmaker Eli Lilly, has been developed and commercialised under a global agreement
US solar producers have sought trade remedies repeatedly, saying their products cannot compete with cheaper Asian panels that dominate the market
US is also considering other options, including working with allies to present a united front to Beijing in demanding a level playing field for global firms
The US Department of Transportation said on Wednesday that Air China agreed to pay a $143,000 fine over delays in 2018 at US airports.
An analysis of final 2021 Census trade data compiled by an economist with the Peterson Institute for International Economics showed China met just 57% of its two-year goods and services targets.
Shares of WuXi Biologics plunge 25% after Commerce Dept adds 33 Chinese entities to its 'unverified list', which requires exporters to go through more procedures before shipping goods
Criminal complaint alleges Shenzhen-based company actively recruited Motorola employees in Malaysia, offering higher salaries and better benefits in exchange for Motorola's trade secrets.
Beijing had only bought 60% of what it said it would and there was little sign it would close the gap in purchases promised by the end of 2021. Later, China called for trade based on mutual respect